Public policy/coalition/comms expert embracing free markets, free people, individual liberty over the tyranny of blobs. Army Mom. Grammie.
Joined April 2009
- Tweets 7,704
- Following 2,612
- Followers 1,120
- Likes 180
416 Photos and videos
Sorry, @JWalters314, it must be so sad and dreary to have such a dismal view of what the rest of us just call “fun.” If you can’t have national fun on Flag Day, I guess you’re doomed to dreary. @BasedMikeLee
The European mind understands it perfectly. This is what imperial decadence looks like: public institutions converted into branded spectacle, civic memory replaced by adrenaline theater, and the People’s House turned into a content backdrop for regime propaganda.
The joke is not that Europe cannot comprehend it. The joke is that America no longer recognizes what it is becoming.
1
91
And let’s hope that injecting a placebo into a terminal patient’s skull went out the door with Prasad and Makary. @FDA_KyleD
10
1,415
Bad parenting or none at all, and a political ruling class that actively teaches the opposite of property rights.
“But these aren’t real New Yorkers”
Last night was a perfect microcosm of what New York has become, and its population denial has led us here.
Your team worked their asses off to bring you a historic championship, but instead of celebrating like normal people, you turned it into an outlet for criminality.
Well, it was just a few… WHAT? Look at the video from all over the city!
These are New Yorkers, and you’ve lost your city. x.com/ScooterCasterNY/status…
2
38
Thank you, @dcexaminer. Happy Flag Day to you!
RESTORING AMERICA: Flag Day on June 14th is a celebration of the Stars and Stripes, the enduring symbol of a nation founded on the idea that people from different backgrounds, beliefs, and circumstances can come together as one people. It is also an opportunity to reflect on whether we are still living up to that promise. | @KerriHT
MORE: trib.al/9k41ALR
23
Sharing thoughts with you in this editorial about the flag, E Pluribus Unum, and where we need to be on this today. Happy Flag Day! washingtonexaminer.com/resto…
20
Jun 12
Really? He employs 200,000 people, not including thousands of vendors. He just made thousands of long time employees millionaires. He gives $500M ish to charity each year and his Neurolink (his own money) is designed to cure many neurological diseases, blindness and deafness. Why is this a problem?
Elon Musk just became the world’s first trillionaire.
Let’s make sure he’s also the last.
3
45
Jun 12
So perfectly said, @RainConsulting You’d think the obvious would actually be obvious.
The FDA’s evidentiary framework was built for large trials and common diseases. ALS is neither.
Rare disease patients deserve advisory committees that understand urgency, totality of evidence, and the cost of delay. The past NurOwn AdComm understood none of this.
When a disease is 100% fatal, “wait for more data” is not a neutral decision. It’s a decision with consequences, costs lives, and is completely unacceptable. @FDA_KyleD @aVoice4ALS @iamalsorg @SecKennedy @houmanhemmati
2
132
Jun 11
I follow FDA news and policy, but did not know about the problem of AdComms until today. Thank you to this author for pointing out even more broken bits at FDA that need a cast. Please fix this. @FDA_KyleD, @SecKennedy & @POTUS. @houmanhemmati @peter_mantas @mike98572986 @PeterPitts @SenRonJohnson @SenRickScott @RepHarshbarger
washingtonexaminer.com/op-ed…
1
1
12
1,749
Kerri (Houston) Toloczko retweeted
Jun 9
🧬 Please read this article 👇 by @ZacharyBrennan at @endpts which outlines how @FDA not following its own policies is risking the demise of @gracescience - a biotech founded by a brilliant Nobel Prize winner that treats an ULTRA-rare pediatric genetic disease with gene therapy.
Despite having manufactured & tested the drug, and having enough to treat most of the kids with it in the USA, FDA is forcing them to make more drug at a cost of tens of millions and potentially years, just to check a box.
Why?
It’s time to be reasonable & common sense. No one is being helped by stonewalling a potential treatment for a devastating genetic disease.
3
1
28
3,393
Hat's off, @SenRonJohnson! Thank you for always standing behind our rare disease families!
I championed Right to Try to give terminal patients the freedom and hope to access promising treatments without years of FDA delays.
Yesterday, I introduced Right to Try 2.0 to expand that freedom for patients needing individualized, one-patient therapies.
This is about medical freedom and putting doctors and patients at the top of the treatment pyramid.
Read more below⬇️
86
It’s not the counting that takes so long. It’s the finding places to hide all the Republican ballots. @honestelections @SaveOurStates @spencerpratt @SteveHiltonx @TPPFelections @HvonSpakovsky @PILFoundation @joshmhelton @CAGOP
1
46
Very happy to hear they fixed it.
Jun 6
It’s on the list
1
192
At the end of the day, people just want to be heard. And then they want officials to turn what they said into action. @spencerpratt is the kind of unicorn we need an entire herd of.
Jun 1
Two days ago, Spencer Pratt held a cookout at Jim Gilliam Park in the Jungles. A week earlier, Rolling 60s territory. Politicians avoid these neighborhoods, scared of the anger from decades of neglect.
Spencer showed up anyway. Broke bread. Listened.
This is a new Los Angeles.
1
181
May 31
Could not agree more! The best “do overs” are the ones that include the ideal leader. @POTUS @realDonaldTrump @SecKennedy
May 30
1
66
Kerri (Houston) Toloczko retweeted
Five days ago I connected Peter Pitts’ argument on delayed approvals to the ongoing #NurOwn debate.
Today, he joins the @BrainstormCell Board.
What makes this noteworthy is that the discussion is shifting from whether regulatory flexibility should exist to how it should be applied.
In diseases with near-certain mortality and profound unmet need, the ethical burden should not rest solely on approving too early. It must also account for approving too late.
Peter Pitts has long been willing to confront that uncomfortable reality: that delay is not a neutral decision, and that patients bear the consequences when systems become more focused on eliminating uncertainty than addressing urgent unmet need.
His experience at the FDA, combined with his willingness to challenge conventional thinking, brings an important perspective to this conversation.
Welcome, @PeterPitts ! I hope your voice helps advance a more patient-centered approach to evaluating therapies for those facing terminal diseases with few remaining options. @FDA_KyleD @houmanhemmati @LoriMills4CA42 @Christina4HD @KerriHT @SecKennedy @aVoice4ALS @MinoShah @DrPatrick @bullishbruk @realDonaldTrump
Important piece by @PeterPitts
NurOwn belongs in this conversation too.
As Pitts wrote, “every delayed approval has a human cost.” For ALS, that cost is brutally literal: roughly 5,000 Americans are diagnosed each year, and most patients die within 2–5 years. (CDC)
While the NurOwn Citizen Petition sits unresolved, nearly 5,000 people with ALS have died waiting.
This is a 100% fatal disease. Patients do not have the luxury of perfect timelines, perfect data, endless process, or regulatory hesitation disguised as rigor.
If a treatment shows signs of extending life and preserving function in ALS, the FDA should be leaning into the urgency to approve, not delay. @houmanhemmati @FDA_KyleD @SecKennedy @DrPatrick @aVoice4ALS 👇
7
12
1,101
Kerri (Houston) Toloczko retweeted
There appears to be a broader cultural shift happening at FDA around rare disease flexibility, single-study evidence discussions, and patient-centered benefit/risk framing.
This is exactly what needs to happen. Now let’s see some serious movement in ALS, HD, and cancer. The US needs to lead in innovation. @houmanhemmati @FDA_KyleD @LoriMills4CA42 @PeterPitts @aVoice4ALS @Christina4HD @bullishbruk
1
12
38
1,519